Getting new medicines developed in Japan is now easier, thanks to regulatory streamlining and changes in the pricing system. Senior Japanese government officials and industry leaders join Endpoints News to discuss the details. Join us to learn how your company can benefit and bring your drug to market faster. Join this virtual event to take a deeper dive into the Japan pharma market and the various opportunities for sponsors.

Thursday, November 14, 2024   |   11:00 AM – 1:00 PM ET
  • 11:00am-11:30am ET: “Japan’s lucrative market opportunity for biotech”
  • 11:30am-12:00pm ET: “Innovative partnering to accelerate patients’ access to new medicines in Japan”
  • 12:oopm-12:30pm ET: “Unlocking Japan: Navigating clinical trials and market potential for global biopharma”
                                                CMIC Featured Speaker: Masako Aoyagi, Head of Project Management, CRO Business, CMIC Group
  • 12:35pm-1:00pm ET: “Dispelling myths about Japan’s pharma regulator”
For more information on each session and to register, please visit: https://events.endpts.com/japan-biotech